US CDC will not publish report showing COVID vaccine effectiveness
"Scientific reports are routinely reviewed at multiple levels to ensure they meet the highest standards before publication," said HHS spokesperson Andrew Nixon.
CORONAVIRUS NEWS
Multiple cases of new COVID-19 variant found by CDC's airport screening program -CBS
Israeli breakthrough: Freeze-dried COVID vaccine needs no refrigeration
Israel kicks off new COVID vaccine campaign targeting JN1 variant: What you need to know
Israel's COVID-19 czar fears new wave combined with flu, urges vaccines
Israel's COVID-19 czar Prof. Salman Zarka calls for the voluntary wearing of face masks in risky places and antigen testing as the Jewish High Holy Days approach.
COVID-19: Likelihood of working from home dependent on money, gender - study
The research is based on the Central Bureau of Statistics Labor Force Survey that, beginning in September 2020, also includes data on the number of hours worked from home.
COVID-19 vaccines can significantly reduce long-COVID risk - Israeli study
A new study from Bar-Ilan University shows that eight of the 10 most commonly reported symptoms were reported between 50% and 80% less often among those who received at least two vaccine doses.
Top scientists join forces to study leading theory behind long COVID
A new research group is gathering top scientists to streamline research and quickly pivot to clinical trials of potential treatments for long COVID.
Feeling nervous? You may be at risk of contracting long COVID - study
Distress was more strongly associated with developing long COVID than physical health risk factors such as obesity, according to new Harvard research.
![Mental health [illustrative]](https://images.jpost.com/image/upload/f_auto,fl_lossy/q_auto/c_fill,g_faces:center,h_448,w_632/435031 "Mental health [illustrative]")
Scientists find COVID-19 antibodies that can make boosters unnecessary
Researchers at Tel Aviv University found two antibodies that neutralize all known strains of COVID-19 with up to 95% efficiency.
COVID-19: Health Min. offers non-mRNA vaccine, alt. for Pfizer, Moderna
It has obtained supplies of Nuvaxovid from the Novavax company. It is a vaccine that protects against serious complications of the pandemic without being based on mRNA.
Men with low testosterone are at increased risk of severe COVID-19 - study
Researchers found that low testosterone—like diabetes, chronic lung disease and heart disease—is a risk factor for hospitalization due to COVID-19.
EU regulator backs two Omicron-adapted COVID boosters
Developed by Moderna and the team of Pfizer and BioNTech, the new so-called bivalent shots combat the BA.1 version of Omicron and the original virus first detected in China.
Could COVID-19 push you closer towards dementia, Alzheimer's?
A new study will spend two years monitoring post-COVID patients over 65 to see if the illness pushed them closer towards dementia.